Jeremy Desai

Apotex plant

Pharma

The hits keep coming: Apotex loses 31 generic approvals

Less than two years after the murder of its founder and with a possible sale in the works, Apotex has lost FDA approvals for 31 of its drugs.

Kyle Blankenship Jul 10, 2019 12:08pm

boardroom

Apotex founder's family weighs sale worth up to $3B: report

Apr 5, 2019 11:55am

Apotex pills

Apotex CEO Jeremy Desai resigns in midst of turmoil

Jan 29, 2018 11:50am

Teva

Teva sues former exec for siphoning trade secrets to boyfriend

Jul 11, 2017 9:53am